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Abstract
Background Butein has been reported to prevent and
partly reverse liver fibrosis in vivo; however, the mecha-
nisms of its action are poorly understood. We, therefore,
aimed to determine the antifibrotic potential of butein.
Methods We assessed the influence of the incubation of
hepatic stellate cells (HSCs) and hepatoma cells (HepG2)
with butein on sensitivity to ethanol- or acetaldehyde-
induced toxicity; the production of reactive oxygen species
(ROS); the expression of markers of HSC activation,
including smooth muscle a-actin (a-SMA) and procollagen
I; and the production of transforming growth factor-b1
(TGF-b1), metalloproteinases-2 and -13 (MMP-2and
MMP-13), and tissue inhibitors of metalloproteinases
(TIMPs). The influence of butein on intracellular signals in
HSCs; i.e., nuclear factor-jB (NFjB), c-Jun N-terminal
kinase (JNK), and p38 mitogen-activated protein kinase
(p38 MAPK) induced by ethanol was estimated.
Results Butein protected HSCs and HepG2 cells against
ethanol toxicity by the inhibition of ethanol- or acetalde-
hyde-induced production of ROS when cells were incu-
bated separately or in co-cultures; butein also inhibited
HSC activation measured as the production of a-SMA and
procollagen I. As well, butein downregulated ethanol- or
acetaldehyde-induced HSC migration and the production
of TGF-b, TIMP-1, and TIMP-2; decreased the activity of
MMP-2; and increased the activity of MMP-13. In ethanol-
induced HSCs, butein inhibited the activation of the p38
MAPK and JNK transduction pathways as well as signifi-
cantly inhibiting the phosphorylation of NF jB inhibitor
(IjB) and Smad3.
Conclusions The results indicated that butein inhibited
ethanol- and acetaldehyde-induced activation of HSCs at
different levels, acting as an antioxidant and inhibitor of
ethanol-induced MAPK, TGF-b, and NFjB/IjB transduc-
tion signaling; this result makes butein a promising agent
for antifibrotic therapies.
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Abbreviations
a-SMA Alpha smooth muscle actin
HSC Hepatic stellate cell
JNK c-Jun N-terminal kinase
MAPK Mitogen-activated protein kinase
MMP Matrix metalloproteinase
NFjB Nuclear factor-jB
ROS Reactive oxygen species
TGF-b1 Transforming growth factor-b1
TIMPs Tissue inhibitors of metalloproteinase
Introduction
Liver fibrosis is caused by a variety of agents, including
chronic viral hepatitis, alcohol toxicity, autoimmune
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disease, and hereditary metabolic disorders. For all of these
diseases there is a common pathologic mechanism that
leads to fibrosis: the generation and proliferation of smooth
muscle a-actin (a-SMA)-positive myofibroblasts of peri-
portal and perisinusoidal origin which arise as a conse-
quence of the activation of hepatic stellate cells (HSCs).
HSCs exist in the normal liver as quiescent retinoid-storing
cells, which, in response to injury, are activated to become
proliferative, profibrogenic cells [1–3]. The activated HSCs
are a rich source of type I and III fibrillar collagen and also
secrete high levels of tissue inhibitors of metalloproteinase
(TIMPs) [4]. Several soluble factors, including growth
factors, cytokines, chemokines, and oxidative stress prod-
ucts, derived from hepatocytes, play a role in the activation
of HSCs. The activation of HSCs is associated with the
sequential expression of several key cytokines and their
surface receptors, including transforming growth factor-b
(TGF-b) and its receptors [5]. Endogenous expression of
TGF-b in the liver induces liver fibrosis, and the blockade
of TGF-b signaling by multiple methods prevents the
progression of liver fibrosis in experimental animals [6].
TGF-b downstream signaling is mediated by Smad2 and
Smad3, which are structurally similar but functionally
distinct. They are differentially activated by TGF-b in
quiescent and activated HSCs and play different roles in
HSC function [7, 8].
The development of liver fibrosis in alcoholics has been
linked to the oxidation of ethanol to the highly reactive
compound acetaldehyde. At concentrations that have been
detected in hepatic venous blood after alcohol consump-
tion, acetaldehyde stimulated type I collagen synthesis and
gene transcription in cultured rat and human HSCs through
protein kinase C (PKC) activation [9]. Acetaldehyde was
also shown to increase nuclear factor-jB (NFjB) (p65) and
its binding to the a2(I) collagen promoter [10] and to
enhance NFjB by a mechanism dependent on the accu-
mulation of H2O2 [11–13]. CYP2E1 is an important source
of reactive oxygen species (ROS) in alcohol-induced injury
and fibrosis, as it generates superoxide (O2
-) and hydrogen
peroxide (H2O2). It has been reported that the inhibition of
CYP2E1 activity by diallylsulfide (DAS) prevented the
induction of collagen I gene expression in rat stellate cells
overexpressing CYP2E1 [14]. Oxidative stress also acti-
vates c-Jun N-terminal kinase (JNK), a protein which
regulates the secretion of proinflammatory cytokines by
cultured HSCs [15, 16].
Matrix metalloproteinases (MMPs), a family of zinc
metallo-endopeptidases, are promptly expressed by HSCs
in response to diverse hepatic toxins. In vitro experiments
have demonstrated the role of MMPs in the activation of
HSCs. Also, the proliferation of HSCs is promoted by
pericellular collagen I proteolysis acting via avb3 integrins
[17]. Conversely, MMPs may also contribute to the
regression of liver fibrosis through cleavage of the fibrillar
extracellular matrix (ECM) and the promotion of apo-
ptosis in the activated HSCs. Thus MMPs play a dual
role in liver fibrosis, depending on the timing of their
production [18].
To prevent the progression of hepatic fibrosis, various
types of compounds that interfere with HSC proliferation
and activation have been developed as antifibrogenic
agents. Among others, butein (3,4,20,40-tetrahydroxychal-
cone), a polyphenolic compound extracted from the stem
bark of cashews and Rhus verniciflua Stokes has been
shown to suppress liver fibrosis induced by carbon tetra-
chloride [19] and to inhibit myofibroblastic differentiation
of rat HSCs [20]. Its derivative, with improved bioavail-
ability, has been shown to have a potent antiproliferative
effect mediated by the activation of ERK, with ERK acti-
vation leading to the transcriptional activation of AP-1 and,
consequently, to heme oxygenase 1 expression in hepatic
stellate cells [21]. However, butein also exhibits anti-
inflammatory and antitumor effects through the activation
of other pathways, such as ERK 1/2 and NF-jB signaling
[21–23].
The aim of this study was to investigate the effect of
butein on the activation of rat HSCs cultured in vitro. To
assess the mechanisms of butein’s influence on HSC acti-
vation, we examined whether butein changed the sensi-
tivity of hepatocytes and HSCs to ethanol cytotoxicity, and
whether it changed the production of ROS in hepatocytes
and HSCs. We also examined whether butein influenced
the production of TGF-b, MMPs, and TIMPs in ethanol-
and acetaldehyde-activated HSCs. In activated HSCs we
examined the influence of butein on intracellular signaling,
such as TGF-b-induced signaling, and NFjB, JNK, and
p38 MAPK activation. Studies were performed with a well-
characterized HSC clone (CFSC-2G cell line) as a model to
investigate HSC activation; data from this model are
comparable to the data obtained from in vivo animal
models, as well as human samples [24]. The CFSC-2G cell
line has a phenotype similar to that of freshly isolated
HSCs [25]. Additionally, in some experiments we also used




A rat HSC cell line, CFSC-2G, was kindly provided by Dr.
Marcos Rojkind (Department of Clinical Investigation,
Walter Reed Army Medical Center, Washington, DC,
USA). HSCs were cultured in Eagle’s medium (MEM),
supplemented with 5 % heat-inactivated fetal calf serum
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(FCS), 1 % nonessential amino acids (NEAA), and 1 %
antibiotic-antimycotic, pH 7.4. The cells were seeded in
tissue culture plates (Falcon, Bedford, MA, USA) and
incubated at 37 C in a humidified atmosphere of 5 % CO2.
Cells were subcultured twice a week by trypsinization in a
0.25 % trypsin–ethylenediamine tetraacetic acid (EDTA)
solution after washing with Ca–Mg-free saline. This non-
tumoral cell line is characterized by low basal levels of
type I collagen gene expression and by the presence of
mRNA for a-SMA; hence, in all experiments we starved
these cells by MEM supplementation with only 0.1 % FCS.
The human hepatoma HepG2 cell line retains many hepa-
tocyte functions and was obtained from the American Type
Culture Collection (Manassas, VA, USA). These cells were
cultured in Eagle’s medium (MEM), supplemented with
10 % heat-inactivated FCS, 2 mM L-glutamine, 1 %
NEAA, 1.5 g/l sodium bicarbonate, and 1 % antibiotic-
antimycotic, pH 7.4. The cells were seeded in tissue culture
plates (Falcon) and incubated at 37 C in a humidified
atmosphere with 5 % CO2. HepG2 cells were subcultured
twice a week by trypsinization in 0.25 % trypsin–EDTA
solution after washing with Ca–Mg-free saline. The culture
media and antibiotics were purchased from Gibco (Grand
Island, NY, USA), and 0.25 % trypsin–EDTA, FCS, and
NEAA were obtained from Sigma-Aldrich (Steinheim,
Germany). In some experiments, Hanks’ balanced salt
solution (HBSS) (Sigma-Aldrich) was used.
The influence of butein on the viability of HSCs
and HepG2 cells treated with ethanol or acetaldehyde
as the ethanol metabolite
In preliminary experiments (data not shown) on the influ-
ence of butein on cell viability and proliferation we
detected that 1–10 lM butein exhibited no toxicity and did
not significantly influence the proliferation of CFSC-2G or
HepG2 cells after 24-h incubation. Therefore, for further
experiments 1 and 10 lM butein was used. HepG2 cells
were grown in 96-well plastic plates (Nunc, Roskilde,
Denmark), at 4 9 104 cells/well. After 24-h incubation, the
medium was replaced with a fresh one with the addition of
2 % FCS and 1 lM or 10 lM butein (Sigma-Aldrich).
HSCs were grown in 96-well plastic plates (Nunc) at a
density of 2 9 104 cells/well in Eagle’s medium (MEM)
supplemented with 5 % FCS. After 24-h incubation, the
medium was replaced with a fresh one with the addition of
0.1 % FCS and 1 or 10 lM butein (Sigma-Aldrich). After
another 24 h of incubation, different ethanol (5–100 mM
for CFSC-2G cells and 5–50 mM for HepG2 cells) and
acetaldehyde concentrations (75–500 lM for CFSC-2G
and 75–175 lM for HepG2 cells) were added. It should be
noted that these ethanol and acetaldehyde concentrations
were chosen in preliminary experiments, in which it was
detected that HepG2 cells were several times more sensi-
tive to ethanol and acetaldehyde toxicity than CSFC-2G.
Ethanol and acetaldehyde were purchased from Merck
(Darmstadt, Germany) and maintained as 1 M stock solu-
tions. The cells treated with ethanol or acetaldehyde
were maintained in closed-lid containers in a humidified
CO2-incubator at 37 C for 24 h. The toxicity of these
chemicals was determined by 3-(4,5-dimethylthiazo-2-yl)-
2,5-diphenyl-tetrazolium bromide (MTT) assay, in which
the yellow tetrazolium salt was metabolized by viable cells
to purple formazan crystals. The HSCs were incubated for
3 h with the MTT solution (5 mg/ml). Formazan crystals
were solubilized overnight in sodium dodecylsulfate (SDS)
buffer (10 % SDS in 0.01 N HCl, Sigma-Aldrich), and the
product was quantified spectrophotometrically by measur-
ing absorbance at a wavelength of 570 nm, using an E-max
Microplate Reader (Molecular Devices, Menlo Park, CA,
USA). The data are presented as percentages of control cell
viability from four independent experiments each with
eight separate cell cultures.
Measurement of superoxide anion (O2
-) production
by cytochrome c reduction assay [26]
HepG2 cells were grown in 96-well plastic plates (4 9 104
cells/well) and HSCs were grown in 96-well plastic plates
(2 9 104 cells/well) for 24 h at 37 C in a humidified
atmosphere of 5 % CO2. Then, the cultures were washed
twice with HBSS, and the culture medium was replaced
with fresh 0.1 % FCS-MEM (CFSC-2G cells) or with 2 %
FCS-MEM (HepG2 cells) with or without 10 lM butein.
The next day, an assay for superoxide anion was per-
formed. Briefly, HBSS (207.5 ll), 12.5 ll of cytochrome c
solution in HBSS (to achieve a final concentration of
75 lM), 5 ll of either superoxide dismutase (SOD) solu-
tion (to achieve a final concentration of 60 U/ml) or 5 ll
HBSS, and 25 ll ethanol solution in HBSS (final concen-
tration of 5, 10, or 50 mM) or acetaldehyde (final con-
centration of 75 or 175 lM) were added to each well on a
96-well plate. Also, control wells were used in which cells
were incubated without ethanol or acetaldehyde. The
microplate was incubated at 37 C for 60 min and trans-
ferred to a microplate reader. The absorbance values at
550 nm (the differences in optical density [OD] between
samples with and without SOD) were converted to nano-
moles of O2
- based on the extinction coefficient of cyto-
chrome c: DE550 = 21 9 10
3 M-1 cm-1. The results were
expressed as nanomoles of O2
- per 1 9 106 cells per
60 min. Four independent experiments were repeated, each
with eight separate cell cultures. All chemicals were pur-
chased from Sigma-Aldrich.
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Migration assay
Cell migration was assessed using
an in vitro wound closure assay
HSCs were plated at a density of 3 9 105 cells/ml on 4-cm
culture dishes (Nunc) (2 ml/dish) in 5 % FCS-MEM for
24 h. Then, one linear wound was scraped in each well
with a sterile pipette tip (P300). The wounded monolayers
were rinsed twice with culture medium to remove all cel-
lular debris, and the medium was replaced with a fresh one
with the addition of 0.1 % FCS-MEM and, in some cul-
tures, also 10 lM butein. After 24-h incubation, 50 mM
ethanol or 175 lM acetaldehyde was added to the wells
with or without butein. Control cells were cultured in
0.1 % FCS-MEM. The number of cells which had migrated
into the wounded area after 24 h was estimated in the
control and in the cultures treated with ethanol that were
pretreated or not with 10 lM butein. Plates were stained by
the May–Gru¨nwald–Giemsa method. The observation was
performed under an Olympus BX51 System Microscope
(Olympus Optical, Tokyo, Japan), and micrographs were
prepared using analySIS software (Soft Imaging System,
Mu¨nster, Germany). Cells which had migrated to the
wounded areas were counted on micrographs, and the
results were expressed as the mean number of cells which
had migrated to 100 selected wounded areas taken from
three micrographs.
Treatment of HSCs with ethanol and 10 lM butein
HSCs were grown in 6-well plastic plates (2 9 105 cells/
ml, 5 ml/well) in 5 % FCS-MEM for 24 h in a humidified
CO2-incubator at 37 C. Then, the medium was replaced
with fresh 0.1 % FCS-MEM with or without 10 lM butein,
and the cells were incubated for another 24 h at 37 C.
After that, the inducer, ethanol, at different concentrations
(final concentration 5, 10 or 50 mM), was added to the
medium (in some experiments 175 lM acetaldehyde was
also used). To exclude only the preincubation effect, in
another experiment HSCs were treated with ethanol first
and after 24-h incubation with butein 10 lM, and param-
eters of cell activation (such as the production of a-SMA
and procollagen I) were measured by western blot. Plates
were prepared in duplicate:
a) after 20 min of incubation and washing twice with
phosphate-buffered saline (PBS), the cells were col-
lected for western blot analysis of phospho- and total
NFjB, phospho- and total IjB, phospho- and total
JNK, and phospho- and total p38 MAPK.
b) after 24 h of incubation, the cultures were washed
twice with PBS, and the cells were harvested for
western blot analysis of a-SMA, procollagen I, TIMP-
1, TIMP-2, MMP-13, and phospho- and total Smad3.
Additionally the cell culture supernatants were centri-
fuged and frozen immediately at -80 C for further cyto-
kine (TGF-b), MMP-2, and TIMP-1 level measurements,
using a sandwich enzyme-linked immunosorbent assay
(ELISA) according to the manufacturer’s instructions;
ELISA kits for the detection of rat proteins were purchased
from R&D Systems. All experiments were performed three
times each with four separate cell cultures for one sample.
Co-cultures of HepG2 cells activated with ethanol
or acetaldehyde with HSCs
HSCs at the density of 2 9 105/ml in MEM medium sup-
plemented with 5 % of FCS were seeded in 6-well plastic
plates. At the same time, HepG2 cells at the density of
1 9 106/ml were seeded into tissue culture inserts with a
membrane (pore diameter 0.4 lm) and incubated for 24 h
at 37 C. After that the HepG2 cells in the inserts were
treated with ethanol (final concentration 50 mM) or acet-
aldehyde (final concentration 175 lM) diluted in MEM
supplemented with 0.1 % of FCS for 3 h at 37 C, washed,
and moved into the cultures of stellate cells in the wells of
plastic plates in which the medium was supplemented with
antioxidant enzymes such as SOD (240 U/ml) and catalase
(CAT; 40 U/ml). Appropriate controls were also prepared.
Cells were co-cultured for 24 h at 37 C and HSCs were
collected for the measurements of a-SMA and procollagen
I expression. Also, cell co-culture supernatants were col-
lected for further TGF-b measurement. Experiments were
done in triplicate (each with three separate cell cultures).
Western blot analysis
HSCs were harvested and lysed in RIPA buffer (50 mM
Tris/HCl pH 7.4, 150 mM NaCl, 1 % Triton X-100, 1 mM
EDTA, 1 % sodium deoxycholate, 0.1 % SDS, 1 mM
Na3VO4, 10 mM NaF, and protease inhibitor cocktail), and
then centrifuged at 10,000 rpm/5 min at 4 C. Proteins
were assayed using a BCA Protein Assay Kit (Pierce,
Rockford, IL, USA). For western blot analysis, superna-
tants of RIPA cell lysates were solubilized in 59SDS
sample buffer (100 mM Tris/HCl pH 6.8, 25 % glycerol,
2 % SDS, 0.01 % bromophenol blue, 3 % b-mercap-
toethanol) and then boiled for 5 min at 100 C. Equal
amounts of the total cellular protein extract were separated
on 10 % SDS-polyacrylamide gel electrophoresis (PAGE)
at 200 V for 1 h under reducing conditions and electro-
transferred in a semi-dry way to polyvinylidine difluoride
membranes (PVDF; Millipore, Whatman) at 15 V for
15 min in a transfer buffer, pH 8.1 (47.8 mM Tris/HCl,
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0.293 % glycine, 20 % methanol). After blocking for
15 min at room temperature with 10 % dried nonfat milk/
TBS/0.1 % Tween 20, the membranes were probed over-
night at ?4 C with primary antibodies (diluted in 1 %
bovine serum albumin [BSA]/TBS/0.1 % Tween 20) as
follows: rabbit polyclonal anti-procollagen type I (1:250;
Santa Cruz Biotechnology, Santa Cruz, CA, USA),
mouse monoclonal anti-a-SMA (1:1000; Sigma-Aldrich),
mouse monoclonal anti-b-actin (1:4000;Sigma-Aldrich), mouse
monoclonal anti-TIMP-1 (1:500; R&D Systems), rabbit
monoclonal anti-TIMP-2 (1:1000; Sigma-Aldrich), rabbit
polyclonal anti-MMP-13 (1:200; USBiological), rab-
bit monoclonal anti-total Smad3 (1:2000; Epitomics),
rabbit monoclonal anti-phospho Smad3 (1:1000; Epito-
mics), rabbit polyclonal anti-total NFjB p65 (1:2000;
Chemicon), rabbit polyclonal anti-phospho NFjB p65
(1:500; Rockland), rabbit polyclonal anti-total IjB-a
(1:2000; Sigma-Aldrich), mouse monoclonal anti-phospho
IjB-a (1:1000; USBiological), rabbit polyclonal anti-total
JNK (1:2000; Sigma-Aldrich), rabbit polyclonal anti-
phospho JNK 1/2 (1:1000; Sigma-Aldrich), rabbit poly-
clonal anti-total p38 (1: 10000; Sigma-Aldrich), and rabbit
polyclonal anti-phospho p38 (1:1000; Sigma-Aldrich).
After repeated washing (TBS/0.1 % Tween 20), the
membranes were incubated with a horseradish peroxidase-
conjugated secondary (anti-rabbit or anti-mouse) antibody
(1:4000, in 1 % BSA/TBS/0.1 % Tween 20; Amersham
Bioscience, Buckinghamshire, UK), and visualized using
an enhanced chemiluminescence reaction (ECL Western
Blotting System; Amersham Bioscence). Protein bands
were scanned, and the band intensities were quantified
using ImageJ densitometry software.
Statistical analysis
Values are expressed as means ± SD. The significance of
differences was determined with the use of analysis of
variance (ANOVA) (Statistica computer package). A
number of statistical tests were used; these included a two-
way ANOVA test with post-hoc Tukey’s test and Wilco-
xon’s paired test for comparisons inside groups. P values of
B0.05 were considered to be significant.
Results
Butein attenuates ethanol- and acetaldehyde-induced
cytotoxicity in HSCs and HepG2 cells
In earlier experiments (data not shown) on the influence of
butein on cell viability and proliferation, we detected that
1–10 lM butein exhibited no toxicity and did not signifi-
cantly influence CFSC-2G and HepG2 cell proliferation
after 24-h incubation. Therefore, for further experiments 1
and 10 lM butein was used. As can be seen from Fig. 1,
preincubation of HSCs with 10 lM butein attenuated the
toxicity of ethanol and acetaldehyde more effectively than
1 lM, especially when the highest concentrations of eth-
anol and acetaldehyde were used; hence, we decided to
apply 10 lM butein in further experiments. It should be
stressed that we detected that HSCs were more resistant
than HepG2 cells to the toxic effect of ethanol and acet-
aldehyde; therefore, in our experiments higher ethanol and
acetaldehyde concentrations were used to treat HSCs than
HepG2 cells.
The influence of butein on reactive oxygen species
(ROS) production in ethanol- or acetaldehyde-treated
HSCs and HepG2 cells
Ethanol and its metabolite acetaldehyde are known as
strong inducers of superoxide anion production in HSCs
and HepG2 cells (Fig. 2). When HSCs and HepG2 cells
were preincubated for 24 h with 10 lM butein and then
ethanol or acetaldehyde was used as an inducer of ‘‘oxi-
dative burst’’, butein significantly inhibited the superoxide
anion production induced by ethanol. In regard to acetal-
dehyde, when CFSC-2G cells were preincubated with bu-
tein the inhibition of superoxide anion production was
stronger than that in HepG2 cells. Butein alone did not
induce O2
- production.
The influence of butein supplementation on ethanol-
induced a-SMA and procollagen I production. Butein
induces HSC quiescence
HSCs that were starved by incubation of the cells in a
medium with 0.1 % FCS were subsequently incubated with
ethanol. The intracellular levels of a-SMA and procollagen
type I were estimated by western blot. Ethanol induced the
production of both a-SMA and procollagen type I in a
concentration-dependent manner (Fig. 3). Preincubation
with 10 lM butein and subsequent activation by different
concentrations of ethanol significantly inhibited the
expression of the markers of HSC activation (Fig. 3a).
Moreover, butein was active not only in protecting cells
against activation but also was effective after activation.
When HSCs were activated by 50 mM ethanol for 24 h and
subsequently incubated with 10 lM butein, inhibition of
their activation was also detected (Fig. 3b).
Butein induces HSC quiescence in co-cultures
of HSCs with ethanol-activated HepG2 cells
HSCs were seeded in 6-well plastic plates and co-cultured
with HepG2 cells seeded into tissue culture inserts with a
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membrane. HepG2 cells in the inserts were treated with
ethanol or acetaldehyde diluted in MEM supplemented
with 0.1 % of FCS for 3 h at 37 C, washed, and moved
into cultures of HSCs in which the medium was supple-
mented with antioxidant enzymes such as SOD (240 U/ml)
















































































Fig. 1a-d The influence of
butein on ethanol- and
acetaldehyde-induced toxicity
in hepatic stellate cells (HSCs;
CFSC-2G) and HepG2 cells.
Cells were preincubated in
medium with 1 or 10 lM butein
for 24 h. Subsequently, ethanol
or acetaldehyde at the indicated
concentrations was added. After
24 h of incubation, the toxicity
was determined by the MTT
method. Values are
means ± SD of results from
four independent experiments
each with eight separate cell
cultures. *Statistically
significant at p B 0.05 in
comparison to cells incubated




















































































































































































Fig. 2 Preincubation of HSCs and HepG2 cells for 24 h with 10 lM
butein inhibits ethanol-induced (a, c) and acetaldehyde-induced (b,
d) superoxide anion production. Cells were preincubated with butein
for 24 h, after which an assay for superoxide anion was performed in
which nanomoles of O2
- per 1 9 106 cells per 60 min were
calculated. Results are expressed as means ± SD of four independent
experiments each with eight separate cell cultures. *Significantly
different from respective controls (cells incubated without ethanol,
acetaldehyde, and butein or treated only with butein), p B 0.05.
#Statistically significant at p B 0.05 in comparison to cells treated
with ethanol or acetaldehyde alone. Butein significantly changed both
the ethanol and acetaldehyde effects, p B 0.01 (two-way analysis of
variance [ANOVA])
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37 C and HSCs were collected for the measurement of
a-SMA and procollagen I expression. As can be seen from
Fig. 4, treatment of HepG2 cells with ethanol or acetal-
dehyde and co-culture of these cells with HSCs caused
enhanced expression of a-SMA and procollagen I in the
HSCs, which could be attenuated by the addition of anti-
oxidant enzymes such as SOD and CAT or the addition of
butein. In contrast to the production of a-SMA, the pro-
duction of procollagen in the co-cultures in which HepG2
cells had been activated with ethanol was significantly
higher than that in HSCs alone. The inhibitory effect of
butein was comparable to the effect of the antioxidant
enzymes, suggesting that the ROS generated by HepG2
cells play a major role in the activation of HSCs.
The influence of butein on HSC motility
When the migration of HSCs was examined by the wound
closure assay (Fig. 5), the addition of butein to the incu-
bation medium significantly inhibited the ethanol- or
acetaldehyde-induced migration of cells in the area of the
linear wound scraped in the monolayer of HSCs.
Butein downregulates TGF-b1, MMP-2, TIMP-1,
and TIMP-2 production in ethanol- or acetaldehyde-
activated HSCs
Preincubation of HSCs with 10 lM butein for 24 h caused
a significant decrease in ethanol-induced TGF-b1 as well
as MMP-2 production (Fig. 6a, c). When HSCs were
activated with acetaldehyde, butein also attenuated TGF-b
production (Fig. 6b). However, butein seemed to have a
weaker effect on the release of MMP-2 into the culture
media after acetaldehyde addition in comparison to the
addition of ethanol (Fig. 6d). Under similar experimental
conditions, ethanol- and acetaldehyde-induced TIMP-1 and
TIMP-2 production was significantly inhibited when mea-
sured by both ELISA and western blot methods (Fig. 7).
Ethanol-induced NFjB activation is antagonized
by butein
NFjB is a ubiquitous transcription factor involved in the
regulation of cytokine production and action and in the
regulation of cell apoptosis. The activation of NFjB is
A B
-
+ butein 10 µM
β-actin
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C 5 mM 10 mM 50 mM
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Fig. 3 Incubation of HSCs with 10 lM butein induces quiescence of
cells activated by ethanol. HSCs were preincubated with butein for
24 h before treatment with ethanol (a) or first activated by ethanol for
24 h and incubated with butein for the next 24 h (b; lane C control).
Markers of HSC activation such as a-smooth muscle actin (a-SMA)
and procollagen I were measured by western blot. b-Actin expression
served as the loading control. On the right, the arrows indicate the
position of the molecular weight markers used in the experiments.
Representative blots are shown. Experiments were done in triplicate
(each with four separate cell cultures), and the bars represent
means ± SD. *Significantly different from respective control (cells
incubated without ethanol); p B 0.05. #Statistically significant differ-
ence, at p B 0.05, in comparison to cells treated with ethanol alone.
?Significantly different from the lower ethanol concentration (5 mM),
??(10 mM); p B 0.01. Butein significantly changed the ethanol
effect, p B 0.01 (two-way ANOVA)
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linked to the phosphorylation and proteolytic degradation
of IjBa [27]. Therefore, we examined the influence of
butein on the level of ethanol-induced NFjB in HSCs and
also on the phosphorylation of NFjB. Moreover, we
examined the total level of IjBa and its phosphorylation.
The experiment revealed that 50 mM ethanol increased
C1      C2   butein butein ethanol 50mM      AcAld 175 M ethanol AcAld



































































Fig. 4 Butein inhibits HSC activation stimulated by co-cultures of
HSCs with HepG2 cells treated with ethanol or acetaldehyde. HSCs
were seeded in 6-well plastic plates. At the same time HepG2 cells
were seeded into tissue culture inserts with a membrane (pore
diameter 0.4 lm) and incubated for 24 h at 37 C. After that, HepG2
cells in the inserts were treated with ethanol or acetaldehyde for 3 h at
37 C, washed, and moved into cultures of stellate cells in the wells of
plastic plates in which the medium was supplemented with antiox-
idant enzymes such as superoxide dismutase (SOD) (240 U/ml) and
catalase (CAT) (40 U/ml). Appropriate controls were also prepared
(C1 HSCs only, C2 HSCs with HepG2 cells without any chemicals).
Cells were co-cultured for 24 h at 37 C and HSCs were collected for
the measurement of a-SMA and procollagen I expression. In
co-culture supernatants transforming growth factor-b (TGF-b) was
also determined (enzyme-linked immunosorbent assay [ELISA]
method). Experiments were done in triplicate (each with three
separate cell cultures), and the bars represent means ± SD. *Signif-
icantly different from respective controls (cells incubated without
ethanol or acetaldehyde); p B 0.05. #Statistically significant at
p B 0.05 in comparison to co-culture where HepG2 cells had been
treated with ethanol or acetaldehyde alone. aSignificantly different in
comparison to ethanol treatment in CFSC-2G only, p B 0.05. Butein
significantly changed the ethanol or acetaldehyde effect, p B 0.01
(two-way ANOVA)
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total levels of NFjB and significantly increased the phos-
phorylation of its inhibitor IjBa, while decreasing the total
level of IjBa. Preincubation of HSCs with 10 lM butein
decreased the total level of ethanol-induced NFjB and
increased the total level of its inhibitor IjBa, while sig-
nificantly inhibiting IjBa phosphorylation (Fig. 8).
Butein influences MAPK activation in HSCs
Because cell growth and the expression of genes involved in
cell growth and cytokine production are widely regulated
through MAPK signal cascades, we assessed the effect of
butein on MAPK activity, including the JNK and p38 path-
ways. Treatment of HSCs with 50 mM ethanol significantly
enhanced the phosphorylation of JNK and p38 MAPK,
indicating the participation of both pathways in ethanol-
induced HSC activation (Fig. 8). Preincubation of HSCs
with 10 lM butein significantly inhibited the ethanol-
induced phosphorylation of both JNK and p38 MAPK,
indicating that at least some butein effects in ethanol-induced
HSCs are mediated by the inhibition of MAPK signaling.
Effect of butein on the TGF-b-signaling pathway
TGF-b signal cascades through Smad2 and Smad3 strongly
regulate the expression of type I collagen genes [10];
therefore, we evaluated the effect of butein on ethanol-
induced phosphorylation of Smad3. Treatment with butein
significantly suppressed the ethanol-induced phosphoryla-
tion of Smad3 by nearly 50 % (Fig. 9).
Butein restores ethanol- and acetaldehyde-inhibited
MMP-13 production
Ethanol- and acetaldehyde-treated HSCs produced less pro-
MMP-13 and active MMP-13 than controls, as shown by
western blot. When the cells were butein protected, the
amounts of both forms: pro-MMP-13 and active MMP- 13,
returned to the control level regardless of the inductor used
(Fig. 10).
Discussion
Our study explored the multiple effects of butein on etha-
nol- or acetaldehyde-activated rat hepatic stellate cells
(HSCs). Pretreatment of HSCs with butein influenced
several parameters of ethanol-induced HSC activation,
causing a decrease in a-SMA and procollagen type I pro-
duction, and inhibiting HSC motility. Moreover, it was
shown that all of these effects were observed not only





















































Fig. 5 Butein inhibits motility of HSCs. A wound healing assay was
performed on HSCs grown to a confluent cell layer in which a wound
was scraped to remove a linear area of cells. The cultures were treated
with 10 lM butein for 24 h and then 50 mM ethanol or 175 lM
acetaldehyde was added, and the cells were allowed 24 h to migrate.
Representative images of different conditions are shown. The
experiment was repeated five times. *Statistically significant at
p B 0.05 in comparison to respective controls (cells not treated or
treated only with butein). #Statistically significant at p B 0.05 in
comparison to cells treated with ethanol or acetaldehyde alone
(Wilcoxon test)
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suggesting that at least two steps of ethanol metabolism
were involved in the activation of the HSCs. Butein
silenced the activation of HSCs induced by both ethanol
and its metabolite, acetaldehyde.
To assess the mechanisms by which butein inhibited
HSC activation, we examined its antioxidative properties.
The antioxidative effects of butein have already been
described. It has been shown to be a potent inhibitor of
lipid peroxidation in rat liver microsomes and to substan-
tially decrease the production of superoxide anion by rat
peritoneal exudate macrophages [28]. The main source of
ROS is from the metabolism of ethanol to acetaldehyde and
subsequently to acetic acid, mainly in hepatocytes but also
in liver stellate cells. Hence, in the present experiment we
used both ethanol and acetaldehyde to induce ‘‘oxidative
burst’’. It is known that both these cell lines are able to
produce ROS during ethanol metabolism. CFSC-2G
express CYP2D6 P450 cytochrome, which metabolizes
ethanol into acetaldehyde [29, 30]; moreover, these cells
can express nicotinamide adenine dinucleotide phosphate,
reduced (NADPH) oxidase enzyme [31], which they use in
ethanol metabolism (supplementary data Table 1). In
HepG2 cells the constitutive expression of CYP3A4,
CYP2C9, CYP2E1, and CYP1A2 [32, 33] has been
detected, and these enzymes are also able to metabolize
ethanol [29, 33]. Alexandre et al. [34] found that growing
HepG2 cells (2–6 days of culture) could be an in vitro
model system to study the regulation of human CYPs by
ethanol (including CYP3A4 and CYP2E1). In our experi-
ments, we usually used 48–72 h HepG2 cultures. Also,
HepG2 cells exhibit little ADH and ALDH activity
[35–37], as we further confirmed with their inhibitors;
pyrazole and disulfiram [38]. In our present experiments,
butein inhibited both the ethanol- and acetaldehyde-
induced production of superoxide anion in HSCs and
HepG2 cells; however, we did not study here exactly which
ROS generating system was inhibited by butein.
To estimate the role of ROS in HSC activation, in our
present study we introduced the model of co-cultures of
ethanol- or acetaldehyde-activated HepG2 cells with HSCs.
In such a model the addition of catalase (CAT) or SOD to
the medium prevented HSC activation, indicating that, at
least in part, HSC activation was mediated by ROS.
Moreover, the addition of butein to the medium mimicked
the action of the antioxidant enzymes. It seems, therefore,
possible that the observed in vivo hepatoprotective activity
of butein [19] is mediated by its antioxidant properties.
Similar co-culture models with established cell lines
derived from different species have been studied before,





























































































































Fig. 6a, b Preincubation of HSCs with 10 lM butein inhibits
ethanol- and acetaldehyde-induced production of TGF-b and matrix
metalloproteinase-2 (MMP-2). The cells were preincubated with
10 lM butein for 24 h and subsequently induced to produce TGF-b
and MMP-2 by the addition of ethanol at the indicated concentrations
or by the addition of 175 lM acetaldehyde. The levels of TGF-b and
MMP-2 were measured by ELISA and are shown as the means ± SD
of three independent experiments each with four separate cell
cultures. *Significantly different from respective controls (cells not
treated or treated only with butein), p B 0.01. #Statistically significant
at p B 0.05 in comparison to cells treated with ethanol or acetalde-
hyde alone. Butein significantly changed the ethanol or acetaldehyde
effect, p B 0.01 (two-way ANOVA)
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co-cultured with CFSC-2G cells [39, 40], and those authors
claimed that the results obtained were comparable to that
obtained with primary HSCs and hepatocytes. We decided
to employ a mixed species culture in order to study the
influence of highly conserved molecules such as ROS and
TGF-b on HSC activation; however, the usefulness of such
co-cultures for other experiments could be limited.
Of particular interest are the interactions between TGF-
b production and ROS formation. In cultured HSCs, TGF-b
increases the production of ROS [13, 41], which in turn
induces the expression of a1(I) procollagen mRNA [42].
ROS have also been identified as mediators of acetalde-
hyde-induced a1(I) procollagen gene expression [12]. The
direct profibrogenic effect of oxidative stress has also been
observed in co-cultures of HSCs with HepG2 cells
overexpressing CYP2E1 [40]. Moreover, we detected
higher TGF-b levels in the medium of co-cultured cells in
which HepG2 cells had been activated with ethanol than in
the separate HSC culture, probably because of the double
source of TGF-b. In such co-cultures procollagen expres-
sion was also enhanced. These findings confirm the active
role of hepatocytes in liver fibrosis [43, 44]. It should be
stressed that in our study butein inhibited both ROS gen-
eration and TGF-b production in HSCs.
A previous study of the mechanisms of the antiprolif-
erative activity of butein has shown that the proliferation
and invasion of bladder cancer cells was inhibited by
butein through the activation of ERK1/2 and NF-jB sig-
naling pathways [23]. The involvement of NF-jB path-
ways in the antitumor and anti-inflammatory activity of
TIMP-2
β-actin
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Fig. 7 The effect of preincubation of HSCs with 10 lM butein on
parameters related to extracellular matrix remodeling induced by
ethanol. Western blot analyses for tissue inhibitor of metalloprotein-
ase-1 (TIMP-1) and TIMP-2 were performed on cell lysates derived
from cells preincubated for 24 h with 10 lM butein and subsequently
incubated for 24 h with the indicated ethanol and acetaldehyde
concentrations. The upper panels show representative blots from
three independent experiments each with four separate cell cultures,
the middle panels show densitometry analysis of bands, and the lower
panels show the TIMP-1 ELISA assay. *Significantly different from
respective controls (C cells not treated, C-butein treated only with
butein), p B 0.01. #Statistically significant in comparison to cells
treated with ethanol or acetaldehyde alone, #p B 0.05, ##p B 0.001.
Butein significantly changed the ethanol (p B 0.01) and acetaldehyde
(p B 0.1) effect (two-way ANOVA)
232 J Gastroenterol (2013) 48:222–237
123
butein has been confirmed in other studies [22]. It is known
that NFjB also participates in HSC activation [45–47]. It
has been demonstrated that NFjB binding activity to jB
binding sites in several genes increases in liver macro-
phages and hepatocytes after CCl4 treatment of rats.
Moreover, the production of proinflammatory cytokines
regulated by NFjB is believed to play a major role in CCl4-
induced liver fibrosis [48, 49]. It has also been observed
that the upregulation of NFjB activation and the expres-
sion of various chemokines and adhesion molecules con-
trolled by NFjB, such as ICAM and MIP-1, is enhanced in
ethanol-fed mice [50]. The key feature of liver fibrosis is
the increase in collagen type I synthesis. It has been
reported that the Col1A2 promoter contains at least two
putative NFjB binding sites [51]. Oxidative stress is the
major factor inducing the phosphorylation of IjB, which
releases NFjB, which then translocates to the nucleus to
activate the transcription of target genes [52]. In our
experiments butein inhibited both ethanol-induced oxida-
tive stress and the phosphorylation of IjB, thus inhibiting
the expression of NFjB-activated genes in HSCs, includ-
ing the expression of procollagen I.
The mechanisms by which ethanol and its metabolites
regulate extracellular matrix (ECM) gene expression as
markers of HSC activation have not been completely elu-
cidated. Several researchers have reported that the MAPK
and PI-3 K pathways are involved [47, 53, 54]. Anania
et al. [47] noted that in rat HSCs, phospho-JNK was ele-
vated following exposure to acetaldehyde, and phosphor-
ylated ERK and p38 were detectable but not significantly
elevated. From our study it seems likely that JNK is the
principal mediator of ethanol-induced a1(I) collagen gene
upregulation in rat HSCs. These findings are consistent
with those reported previously by McCarroll et al. [15],
who described that in rat pancreatic stellate cells (PSCs)
ethanol and acetaldehyde at clinically relevant concentra-
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Fig. 8 The effect of preincubation of HSCs with 10 lM butein on the
phosphorylation of nuclear factor jB (NFjB), nuclear factor jB
inhibitor (IjB), c-Jun N-terminal kinase (JNK), and p38 mitogen-
activated protein kinase (MAPK; p38). The cells were preincubated
with 10 lM butein for 24 h and subsequently exposed or not to
50 mM ethanol for 20 min. The relative densitometry readings
(mean ± SD) from three independent experiments each with four
separate cell cultures are shown in the lower panel. The upper panel
shows representative blots of total (t) and phosphorylated (p) forms of
NFjB, IjB, JNK, and p38 MAPK. *Significantly different from
respective controls (cells not treated or treated only with butein),
*p B 0.05, **p B 0.001. #Statistically significant at p B 0.05 in
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Fig. 9 The effect of preincubation of HSCs with 10 lM butein on the
phosphorylation of Smad3. The cells were preincubated with 10 lM
butein for 24 h and then exposed to 50 mM ethanol for 24 h. The
amounts of phosphorylated and total Smad3 (used as loading control)
were measured by western blotting (lower panel). The upper panel
shows representative blots. Each figure is representative of three
independent experiments each with four separate cell cultures. Band
intensities were measured, and the ratio of phosphorylated Smad3 in
the absence of butein and ethanol was used as a control (100 %). The
values shown are means ± SD. *Significantly different from respec-
tive controls (cells not treated or treated only with butein), p B 0.05.
#Statistically significant at p B 0.05 in comparison to cells treated
with ethanol (Wilcoxon test)
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and p38 MAPK. In a study showing that the ethanol- and
acetaldehyde-induced activation of MAPK was blocked by
the antioxidant N-acetyl-cysteine, the role of oxidative
stress in the signal transduction was suggested [55]. The
JNK pathway may be involved in the migration of HSCs
within the Disse space to the sites of tissue damage,
because it has been shown that the JNK inhibitor SP
600125 inhibits HSC migration induced by a TGF-b signal
[47, 54]. The same inhibitor in vitro significantly reduced
fibrosis in mice after CCL4 treatment [56]. It was described
that butein inhibited bile acid-induced hepatocyte apoptosis
through a JNK-dependent pathway [57]. The results of our
study confirm the involvement of the p38 and JNK path-
ways in ethanol-induced HSC activation. Moreover, we
found that JNK activation occurred concomitantly with
enhanced HSC migratory activity. Butein inhibited both
JNK phosphorylation and HSC migration. It has also been
reported that the inhibition of either p38 MAPK or Smad
signaling reduced a1(I) collagen gene expression in
untreated HSCs, and when both signaling pathways were
simultaneously inhibited, a1(I) collagen gene expression
was essentially blocked [58]. These data indicate that not
only MAPK pathways but also TGF-b-induced signaling is
important in the activation of HSCs. In our study, butein
also significantly inhibited the phosphorylation of Smad3,
suggesting that it can inhibit cellular processes upstream of
both MAPK and TGF-b-induced signaling, probably by
mechanisms involving oxidative stress, which, as described
earlier, are responsible for the activation of MAPK and
TGF-b production in HSCs. Recently it has been reported
that butein inhibits the migration and invasion of human
hepatocarcinoma cells through suppressing the ERK, JNK,
and p38 signaling pathways [59]. These observations
confirmed our results that butein may inhibit multiple
signaling pathways, influencing the phenotype of target
cells.
Our study has shown that HSCs can be a rich source of
several MMPs, among others MMP-2 and MMP-13.
Ethanol significantly inhibited MMP-13 and increased the
level and activity of MMP-2, as detected by western blot
and ELISA, respectively. MMP-2 is known to degrade
basement membrane collagen; hence, its production in
early stages of cell activation may be profibrogenic; how-
ever, the later overexpression of MMP-2 may be important
in the remodeling of the matrix during tissue repair
processes [18]. Studies with HSCs have established that,
when activated, HSCs synthesize increased ECM proteins,
particularly fibrillar collagen, but shut-down the expression
of proteases such as MMP-13, which degrade fibrillar
collagen [60–62]. Therefore, the restoration by butein of
the total level and activity of MMP-13, as well as the
reduction of the MMP-2 level observed in our study can be
considered as antifibrogenic activity.
Regulation of ECM synthesis and its degradation by
MMPs and their inhibitors (TIMPs) is a complex process.
In general, TIMPs inhibit MMP activity by binding to
active sites of MMPs. Our study has shown that TIMP-1
and TIMP-2 secretion was induced in HSCs by ethanol.
This finding is similar to previously reported results
with HSCs demonstrating significant TIMP expression
after HSC activation [41, 63, 64]. In our study, butein
significantly inhibited the production of both TIMP-1 and
TIMP-2. As TIMP-1 has been described [65] to have an
antiapoptotic effect on activated HSCs, such a decrease in
its production could be beneficial for the resolution of liver
fibrosis.
Summing up, the results of our experiments revealed
that butein can exert antifibrotic activity by silencing eth-
anol- or acetaldehyde-activated HSCs. Butein inhibited
ethanol-induced ROS production in HSCs and HepG2
cells, and this inhibition seems to be a key mechanism in its
AcAld 175 μM         - - - -
Ethanol 50 mM        - - - -
+ +
+            +



















































Fig. 10 Preincubation of HSCs with 10 lM butein restores the
production of MMP-13 decreased by ethanol or acetaldehyde.
Western blot analysis for MMP-13 was performed on cell lysates
derived from cells preincubated for 24 h with 10 lM butein and
subsequently incubated for 24 h with the indicated ethanol or
acetaldehyde concentrations. The representative western blots are
shown in the upper panel. Each bar in the lower panel represents the
mean ± SD from four independent experiments. *Significantly
different from respective controls (cells not treated or treated only
with butein), p B 0.01. #Statistically significant at p B 0.05 in
comparison to cells treated with ethanol or acetaldehyde alone.
Butein significantly changed the ethanol and acetaldehyde effect,
p B 0.01 (two-way ANOVA)
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inhibitory action on a-SMA and procollagen I expression in
HSCs, which was confirmed in co-culture experiments in
which ROS-producing ethanol-treated HepG2 cells
induced the activation of HSCs. This effect was attenuated
by butein (Fig. 11). For the first time, butein was also
shown to inhibit TGF-b production, probably by its
inhibitory action on the NF-jB pathway. Moreover, butein
attenuated HSC activation via the downregulation of eth-
anol-induced p38 MAPK, JNK, and TGF-b signaling
activation. The enhancement by butein of MMP-13 pro-
duction by HSCs and the inhibition of MMP-2, TIMP-1,
and TIMP-2 production by these cells seem to be additional
mechanisms of its antifibrotic activity.
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